Drug Shortage Report for NEO-SYNEPHRINE
| Report ID | 107703 |
| Drug Identification Number | 02241980 |
| Brand name | NEO-SYNEPHRINE |
| Common or Proper name | Neo-Synephrine |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE |
| Strength(s) | 1% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 1ML / AMP |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-04-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-03-04 | English | Compare |
| v2 | 2020-03-04 | French | Compare |
| v3 | 2020-03-04 | French | Compare |
| v4 | 2020-04-17 | English | Compare |
| v5 | 2020-04-17 | French | Compare |
| v6 | 2020-04-18 | English | Compare |
Showing 1 to 6 of 6